loading
Schlusskurs vom Vortag:
$2.68
Offen:
$2.64
24-Stunden-Volumen:
121.00K
Relative Volume:
0.31
Marktkapitalisierung:
$127.96M
Einnahmen:
$2.76M
Nettoeinkommen (Verlust:
$-49.12M
KGV:
-1.96
EPS:
-1.5
Netto-Cashflow:
$-46.21M
1W Leistung:
-8.85%
1M Leistung:
+2.98%
6M Leistung:
-26.62%
1J Leistung:
-58.78%
1-Tages-Spanne:
Value
$2.60
$2.94
1-Wochen-Bereich:
Value
$2.60
$3.29
52-Wochen-Spanne:
Value
$2.37
$8.8699

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Name
Firmenname
Orchestra Biomed Holdings Inc
Name
Telefon
646-343-9298
Name
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Name
Mitarbeiter
70
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
OBIO's Discussions on Twitter

Vergleichen Sie OBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OBIO
Orchestra Biomed Holdings Inc
2.94 127.96M 2.76M -49.12M -46.21M -1.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.34 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.45 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.02 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.31 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.27 28.51B 3.81B -644.79M -669.77M -6.24

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-20 Eingeleitet BTIG Research Buy
2025-01-02 Eingeleitet Barclays Overweight
2024-08-22 Eingeleitet H.C. Wainwright Buy
2024-07-25 Eingeleitet B. Riley Securities Buy
2024-01-19 Eingeleitet Jefferies Buy
2023-02-24 Eingeleitet Piper Sandler Overweight
2023-02-07 Eingeleitet Chardan Capital Markets Buy
Alle ansehen

Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten

pulisher
Jun 18, 2025

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built - GlobeNewswire

Jun 18, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Makes New Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Sells 7,836 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

(OBIO) Trading Advice - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 02, 2025

Orchestra Biomed Reports Increased Losses Amid Revenue Growth - TipRanks

Jun 02, 2025
pulisher
May 30, 2025

B. Riley Cuts Price Target on Orchestra BioMed Holdings to $12 From $15, Keeps Buy Rating - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stake Increased by Northern Trust Corp - Defense World

May 30, 2025
pulisher
May 28, 2025

Orchestra BioMed: Two Best-In-Class Devices And Promising Partnerships - Seeking Alpha

May 28, 2025
pulisher
May 21, 2025

Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN

May 21, 2025
pulisher
May 19, 2025

How To Trade (OBIO) - news.stocktradersdaily.com

May 19, 2025
pulisher
May 19, 2025

The Manufacturers Life Insurance Company Raises Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 19, 2025
pulisher
May 18, 2025

FY2026 Earnings Estimate for OBIO Issued By Chardan Capital - Defense World

May 18, 2025
pulisher
May 15, 2025

Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation - MSN

May 15, 2025
pulisher
May 14, 2025

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 14, 2025
pulisher
May 14, 2025

Chardan Capital Maintains Buy Rating on OBIO with $20 Price Targ - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Barclays PLC Boosts Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 14, 2025
pulisher
May 14, 2025

Wells Fargo & Company MN Buys 3,992 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 14, 2025
pulisher
May 14, 2025

Orchestra BioMed HoldingsBreakthrough Device Designation Gives Speculative Optimism - Seeking Alpha

May 14, 2025
pulisher
May 13, 2025

Chardan Capital Maintains Buy Rating on OBIO with $20 Price Target | OBIO Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Orchestra BioMed (OBIO) Surpasses Revenue Estimates with Strong Q1 Growth | OBIO Stock News - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy and IDE Approval for Virtue SAB Trial - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Orchestra BioMed Reports First Quarter 2025 Financial - GlobeNewswire

May 12, 2025
pulisher
May 09, 2025

4 No-Brainer Stocks to Buy Right Now - The Globe and Mail

May 09, 2025
pulisher
May 09, 2025

(OBIO) On The My Stocks Page - news.stocktradersdaily.com

May 09, 2025
pulisher
May 08, 2025

Orchestra BioMed receives FDA approval to initiate Virtue Trial - Med-Tech Insights

May 08, 2025
pulisher
May 08, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Sold by Price T Rowe Associates Inc. MD - The AM Reporter

May 08, 2025
pulisher
May 08, 2025

RTW INVESTMENTS, LP Increases Stake in Orchestra BioMed Holdings Inc - GuruFocus

May 08, 2025
pulisher
May 07, 2025

ORCHESTRA BIOMED Earnings Preview: Recent $OBIO Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed’s AVIM Therapy Global Intellectual - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed (OBIO) Expands Patent Portfolio for AVIM Therap - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed Expands Patent Portfolio with 10 New Patents for Hypertension Treatment, Totaling 120 Global Patents - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - MSN

May 07, 2025
pulisher
May 06, 2025

BlackRock, Inc. Reduces Stake in Orchestra BioMed Holdings Inc. - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Orchestra BioMed (NASDAQ:OBIO) Price Target Lowered to $12.00 at Barclays - Defense World

May 06, 2025
pulisher
May 06, 2025

Orchestra BioMed Holdings (OBIO) Target Price Adjustment by Barc - GuruFocus

May 06, 2025
pulisher
May 05, 2025

Barclays Adjusts Price Target for Orchestra BioMed (OBIO) | OBIO Stock News - GuruFocus

May 05, 2025
pulisher
May 04, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by JPMorgan Chase & Co. - Defense World

May 04, 2025
pulisher
May 01, 2025

OBIO: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

May 01, 2025
pulisher
May 01, 2025

How did Orchestra BioMed Holdings Inc (OBIO) fare last session? - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment - MyChesCo

May 01, 2025
pulisher
May 01, 2025

Orchestra Biomed sees $149,201 stock purchase by RTW Investments By Investing.com - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

Orchestra BioMed Holdings Inc [OBIO] Records 200-Day SMA of $5.25 - knoxdaily.com

May 01, 2025
pulisher
May 01, 2025

Orchestra BioMed to Present at Jefferies Global Healthcare Conference - MyChesCo

May 01, 2025

Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.00
price up icon 1.52%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):